Voglibose
Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis[1].
Product Specifications
CAS Number
83480-29-9
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Glycosidase
Type
Natural Products
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Voglibose.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 250 mg/mL (ultrasonic)
Smiles
O[C@@H]1[C@@](O)(CO)C[C@H](NC(CO)CO)[C@H](O)[C@H]1O
Molecular Formula
C10H21NO7
Molecular Weight
267.28
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Human Interleukin 12 p40 Chemiluminescent Immunoassay Kit
Recombinant Solanum lycopersicum 14-3-3 protein 9 (TFT9)
Recombinant Solanum lycopersicum 14-3-3 protein 9 (TFT9)
Recombinant Solanum lycopersicum 14-3-3 protein 9 (TFT9)
Recombinant Solanum lycopersicum 14-3-3 protein 9 (TFT9)